Axana Rodriguez-Torres1, Meredith Murphy1, Christina Kourkoulis1, Kristin Schwab1, Alison M Ayres1, Charles J Moomaw1, Soo Young Kwon1, Jimmy V Berthaud1, M Edip Gurol1, Steven M Greenberg1, Anand Viswanathan1, Christopher D Anderson1, Matthew Flaherty1, Michael L James1, Lee Birnbaum1, Gene Yong Sung1, Gunjan Parikh1, Amelia K Boehme1, Douglas Mayson1, Kevin N Sheth1, Chelsea Kidwell1, Sebastian Koch1, Michael Frankel1, Carl D Langefeld1, Fernando D Testai1, Daniel Woo1, Jonathan Rosand1, Alessandro Biffi2. 1. From the University of California Irvine School of Medicine (A.R.-T.); Hemorrhagic Stroke Research Program (A.R.-T., M.M., C. Kourkoulis, K.S., A.M.A., M.E.G., S.M.G., A.V., C.D.A., J.R., A.B.), and Department of Neurology (A.R.-T., M.M., C. Kourkoulis, M.E.G., S.M.G., A.V., C.D.A., J.R., A.B.), Massachusetts General Hospital, Boston; Department of Neurology and Rehabilitation Medicine (C.J.M., S.Y.K., M. Flaherty, D.W.), University of Cincinnati, OH; Department of Neurology (J.V.B.), University of Virginia Medical Center, Charlottesville; Department of Neurology (M.L.J.), Duke University Hospital, Durham, NC; Department of Neurology and Neurosurgery (L.B.), University of Texas Health Science Center at San Antonio; Department of Neurology (G.Y.S.), Keck School of Medicine of University of Southern California, Los Angeles; Department of Neurology (G.P.), University of Maryland Medical Center, Baltimore; Department of Neurology (A.K.B.), Columbia University, New York, NY; Department of Neurology (D.M.), Georgetown University Medical Center, Washington, DC; Department of Neurology (K.N.S.), Yale University School of Medicine, New Haven, CT; Department of Neurology (C. Kidwell), University of Arizona College of Medicine, Tucson; Department of Neurology (S.K.), University of Miami Health System, FL; Department of Neurology (M. Frankel), Emory University School of Medicine, Atlanta, GA; Department of Biostatistical Sciences (C.D.L.), Wake Forest School of Medicine, Winston-Salem, NC; and Department of Neurology and Rehabilitation (F.D.T.), University of Illinois at Chicago College of Medicine. 2. From the University of California Irvine School of Medicine (A.R.-T.); Hemorrhagic Stroke Research Program (A.R.-T., M.M., C. Kourkoulis, K.S., A.M.A., M.E.G., S.M.G., A.V., C.D.A., J.R., A.B.), and Department of Neurology (A.R.-T., M.M., C. Kourkoulis, M.E.G., S.M.G., A.V., C.D.A., J.R., A.B.), Massachusetts General Hospital, Boston; Department of Neurology and Rehabilitation Medicine (C.J.M., S.Y.K., M. Flaherty, D.W.), University of Cincinnati, OH; Department of Neurology (J.V.B.), University of Virginia Medical Center, Charlottesville; Department of Neurology (M.L.J.), Duke University Hospital, Durham, NC; Department of Neurology and Neurosurgery (L.B.), University of Texas Health Science Center at San Antonio; Department of Neurology (G.Y.S.), Keck School of Medicine of University of Southern California, Los Angeles; Department of Neurology (G.P.), University of Maryland Medical Center, Baltimore; Department of Neurology (A.K.B.), Columbia University, New York, NY; Department of Neurology (D.M.), Georgetown University Medical Center, Washington, DC; Department of Neurology (K.N.S.), Yale University School of Medicine, New Haven, CT; Department of Neurology (C. Kidwell), University of Arizona College of Medicine, Tucson; Department of Neurology (S.K.), University of Miami Health System, FL; Department of Neurology (M. Frankel), Emory University School of Medicine, Atlanta, GA; Department of Biostatistical Sciences (C.D.L.), Wake Forest School of Medicine, Winston-Salem, NC; and Department of Neurology and Rehabilitation (F.D.T.), University of Illinois at Chicago College of Medicine. abiffi@partners.org.
Abstract
OBJECTIVE: To clarify whether recurrence risk for intracerebral hemorrhage (ICH) is higher among black and Hispanic individuals and whether this disparity is attributable to differences in blood pressure (BP) measurements and their variability. METHODS: We analyzed data from survivors of primary ICH enrolled in 2 separate studies: (1) the longitudinal study conducted at Massachusetts General Hospital (n = 759), and (2) the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) study (n = 1,532). Participants underwent structured interview at enrollment (including self-report of race/ethnicity) and were followed longitudinally via phone calls and review of medical records. We captured systolic BP (SBP) and diastolic BP measurements, and quantified variability as SBP and diastolic BP variation coefficients. We used multivariable (Cox regression) survival analysis to identify risk factors for ICH recurrence. RESULTS: We followed 2,291 ICH survivors (1,121 white, 529 black, 605 Hispanic, and 36 of other race/ethnicity). Both black and Hispanic patients displayed higher SBP during follow-up (p < 0.05). Black participants also displayed greater SBP variability during follow-up (p = 0.032). In univariable analyses, black and Hispanic patients were at higher ICH recurrence risk (p < 0.05). After adjusting for BP measurements and their variability, both Hispanic (hazard ratio = 1.51, 95% confidence interval 1.14-2.00, p = 0.004) and black (hazard ratio = 1.98, 95% confidence interval 1.36-2.86, p < 0.001) patients remained at higher risk of ICH recurrence. CONCLUSION: Black and Hispanic patients are at higher risk of ICH recurrence; hypertension severity (average BP and its variability) does not fully account for this finding. Additional studies will be required to further elucidate determinants for this health disparity.
OBJECTIVE: To clarify whether recurrence risk for intracerebral hemorrhage (ICH) is higher among black and Hispanic individuals and whether this disparity is attributable to differences in blood pressure (BP) measurements and their variability. METHODS: We analyzed data from survivors of primary ICH enrolled in 2 separate studies: (1) the longitudinal study conducted at Massachusetts General Hospital (n = 759), and (2) the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) study (n = 1,532). Participants underwent structured interview at enrollment (including self-report of race/ethnicity) and were followed longitudinally via phone calls and review of medical records. We captured systolic BP (SBP) and diastolic BP measurements, and quantified variability as SBP and diastolic BP variation coefficients. We used multivariable (Cox regression) survival analysis to identify risk factors for ICH recurrence. RESULTS: We followed 2,291 ICH survivors (1,121 white, 529 black, 605 Hispanic, and 36 of other race/ethnicity). Both black and Hispanic patients displayed higher SBP during follow-up (p < 0.05). Black participants also displayed greater SBP variability during follow-up (p = 0.032). In univariable analyses, black and Hispanic patients were at higher ICH recurrence risk (p < 0.05). After adjusting for BP measurements and their variability, both Hispanic (hazard ratio = 1.51, 95% confidence interval 1.14-2.00, p = 0.004) and black (hazard ratio = 1.98, 95% confidence interval 1.36-2.86, p < 0.001) patients remained at higher risk of ICH recurrence. CONCLUSION: Black and Hispanic patients are at higher risk of ICH recurrence; hypertension severity (average BP and its variability) does not fully account for this finding. Additional studies will be required to further elucidate determinants for this health disparity.
Authors: Kyle B Walsh; Daniel Woo; Padmini Sekar; Jennifer Osborne; Charles J Moomaw; Carl D Langefeld; Opeolu Adeoye Journal: Circulation Date: 2016-10-13 Impact factor: 29.690
Authors: J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo Journal: Stroke Date: 2015-05-28 Impact factor: 7.914
Authors: Darin B Zahuranec; Jeffrey J Wing; Dorothy F Edwards; Ravi S Menon; Stephen J Fernandez; Richard E Burgess; Ian A Sobotka; Laura German; Anna J Trouth; Nawar M Shara; M Chris Gibbons; Bernadette Boden-Albala; Chelsea S Kidwell Journal: Stroke Date: 2012-08-16 Impact factor: 7.914
Authors: Alessandro Biffi; Christopher D Anderson; Thomas W K Battey; Alison M Ayres; Steven M Greenberg; Anand Viswanathan; Jonathan Rosand Journal: JAMA Date: 2015-09-01 Impact factor: 56.272
Authors: Thorsten Steiner; Rustam Al-Shahi Salman; Ronnie Beer; Hanne Christensen; Charlotte Cordonnier; Laszlo Csiba; Michael Forsting; Sagi Harnof; Catharina J M Klijn; Derk Krieger; A David Mendelow; Carlos Molina; Joan Montaner; Karsten Overgaard; Jesper Petersson; Risto O Roine; Erich Schmutzhard; Karsten Schwerdtfeger; Christian Stapf; Turgut Tatlisumak; Brenda M Thomas; Danilo Toni; Andreas Unterberg; Markus Wagner Journal: Int J Stroke Date: 2014-08-24 Impact factor: 5.266
Authors: Rita V Krishnamurthi; Valery L Feigin; Mohammad H Forouzanfar; George A Mensah; Myles Connor; Derrick A Bennett; Andrew E Moran; Ralph L Sacco; Laurie M Anderson; Thomas Truelsen; Martin O'Donnell; Narayanaswamy Venketasubramanian; Suzanne Barker-Collo; Carlene M M Lawes; Wenzhi Wang; Yukito Shinohara; Emma Witt; Majid Ezzati; Mohsen Naghavi; Christopher Murray Journal: Lancet Glob Health Date: 2013-10-24 Impact factor: 26.763
Authors: Sarah L Stevens; Sally Wood; Constantinos Koshiaris; Kathryn Law; Paul Glasziou; Richard J Stevens; Richard J McManus Journal: BMJ Date: 2016-08-09
Authors: Evangelos Pavlos Myserlis; Ernst Mayerhofer; Jessica R Abramson; Kay-Cheong Teo; Bailey E Montgomery; Lansing Sugita; Andrew D Warren; Joshua N Goldstein; Mahmut Edip Gurol; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Christopher D Anderson; Jonathan Rosand Journal: Eur Stroke J Date: 2022-04-27
Authors: Jessica R Abramson; Juan Pablo Castello; Sophia Keins; Christina Kourkoulis; Axana Rodriguez-Torres; Evangelos Pavlos Myserlis; Haitham Alabsi; Andrew D Warren; Jonathan Q A Henry; M Edip Gurol; Anand Viswanathan; Steven M Greenberg; Amytis Towfighi; Lesli Skolarus; Christopher D Anderson; Jonathan Rosand; Alessandro Biffi Journal: Neurology Date: 2022-02-07 Impact factor: 11.800
Authors: Juan Pablo Castello; Marco Pasi; Jessica R Abramson; Axana Rodriguez-Torres; Sandro Marini; Stacie Demel; Lee Gilkerson; Patryk Kubiszewski; Andreas Charidimou; Christina Kourkoulis; Zora DiPucchio; Kristin Schwab; M Edip Gurol; Anand Viswanathan; Christopher D Anderson; Carl D Langefeld; Matthew L Flaherty; Amytis Towfighi; Steven M Greenberg; Daniel Woo; Jonathan Rosand; Alessandro Biffi Journal: Neurology Date: 2021-04-21 Impact factor: 9.910
Authors: Patryk Kubiszewski; Lansing Sugita; Christina Kourkoulis; Zora DiPucchio; Kristin Schwab; Christopher D Anderson; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Jonathan Rosand; Alessandro Biffi Journal: JAMA Neurol Date: 2020-08-31 Impact factor: 18.302
Authors: Audrey C Leasure; Zachary A King; Victor Torres-Lopez; Santosh B Murthy; Hooman Kamel; Ashkan Shoamanesh; Rustam Al-Shahi Salman; Jonathan Rosand; Wendy C Ziai; Daniel F Hanley; Daniel Woo; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Neurology Date: 2019-12-12 Impact factor: 11.800